★ Sign in to follow
RC

R Connor

GB·RNS (LSE)
GlaxoSmithKline plc
Total declarations
69
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (2 ops.)
€222k

Latest filing published 13 May 2021 for GlaxoSmithKline plc, €312.

Filing timeline

BuySale
R Connor

Insider track record

Disclosed buys
0
Disclosed sells
2
Signal history

R Connor: trading record in brief

R Connor is a declared insider of GlaxoSmithKline plc, with filings sourced from RNS (LSE). Over a trading history stretching from 14 February 2018 to 12 May 2021, the count stands at 69 filings.

Every open-market trade on record is a sale: 2 sales worth €222k. Outside the open market, there are 67 share grants. 2021 to date brings no purchases and 1 sale.

Most recently, on 13 May 2021, the filings show a share grant worth €312 in GlaxoSmithKline plc. Filings reach the RNS (LSE) feed a median of 2 days after the trade. The legal deadline for notifying a trade is three business days (UK MAR). Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from RNS (LSE) disclosures alone and does not predict where the share price will go.

Companies and markets linked to R Connor

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations69 total
  • ◆
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    268 GBP0FCA-NSM
    20 shares@ £13.407London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3974287-1
  • ◆
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    45,338 GBP0FCA-NSM
    3,500.798 shares@ £12.9508London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3944285-1
  • ◆
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    232 GBP0FCA-NSM
    18 shares@ £12.9061London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3943193-1
  • ◆
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    10,427 GBP0FCA-NSM
    789 shares@ £13.216London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3943052-2
  • ◆
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    1,432 GBP0FCA-NSM
    109 shares@ £13.1367London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3938809-1
  • ◆
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    253 GBP0FCA-NSM
    20 shares@ £12.671London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3908301-1
  • ◆
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    0FCA-NSM
    14,551 sharesN/AISIN GB0009252882FCA-NSM:3897443-2
  • ▼
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    83,047 GBP0FCA-NSM
    6,857 shares@ £12.1113N/AISIN GB0009252882FCA-NSM:3897443-3
  • ◆
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    0FCA-NSM
    63,501 sharesLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3882407-1
  • ◆
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    0FCA-NSM
    135,107 sharesN/AISIN GB0009252882FCA-NSM:3879317-2
  • ◆
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    1M GBP0FCA-NSM
    78,431.373 shares@ £12.75n/aISIN GB0009252882FCA-NSM:3878377-0
  • ◆
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    0FCA-NSM
    10,057 sharesN/AISIN GB0009252882FCA-NSM:3878373-3
  • ◆
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    0FCA-NSM
    218,299 sharesN/AISIN GB0009252882FCA-NSM:3878367-3
  • ◆
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    254 GBP0FCA-NSM
    20 shares@ £12.717London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3875131-1
  • ◆
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    9,322 GBP0FCA-NSM
    669 shares@ £13.934London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3851939-2
  • ◆
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    23,530 GBP0FCA-NSM
    1,674.869 shares@ £14.0488London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3850615-1
  • ◆
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    1,165 GBP0FCA-NSM
    84 shares@ £13.8719London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3847444-1
  • ◆
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    249 GBP0FCA-NSM
    18 shares@ £13.8428London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3844188-1
  • ◆
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    252 GBP30FCA-NSM
    18 shares@ £14.0272100.0% of flowLondon Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3811317-1
  • ◆
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    263 GBP0FCA-NSM
    18 shares@ £14.6233London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3777599-1
  • ◆
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    9,194 GBP0FCA-NSM
    645 shares@ £14.254London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3748390-2
  • ◆
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    23,224 GBP0FCA-NSM
    1,612.654 shares@ £14.4008London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3746934-1
  • ◆
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    230 GBP0FCA-NSM
    16 shares@ £14.3994London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3746905-1
  • ◆
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    1,141 GBP0FCA-NSM
    80 shares@ £14.2576London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3746881-1
  • ◆
    R Connor
    President, Global VaccinesExecutivesGlaxoSmithKline plc
    274 GBP0FCA-NSM
    18 shares@ £15.2033London Stock Exchange (XLON)ISIN GB0009252882FCA-NSM:3714306-1

25 of 69 declarations

Related entities

No related entities found.